Medical Bulletin 30/March/2026

Here are the top medical news for today:

Study Links Heart Health to Increased Fracture Risk in Postmenopausal Women

Postmenopausal women face a significantly increased risk of Osteoporosis and fractures due to declining estrogen levels. A new study from Tulane University highlights that Cardiovascular Disease risk may further elevate the likelihood of fractures, particularly in vulnerable populations.

Published in The Lancet Regional Health – Americas, the study analyzed data from over 21,000 women in the Women's Health Initiative. Researchers used the PREVENT Score to estimate participants’ 10-year cardiovascular risk, categorizing them into low, borderline, intermediate, and high-risk groups.

The findings revealed a strong association between heart health and fracture risk. Women in the high cardiovascular risk group had a 93% higher risk of hip fractures compared to those in the low-risk group, while those in the intermediate group had a 33% increased risk. The link was particularly pronounced in women under 65 and extended to fractures in major areas such as the spine, forearm, and shoulder.

According to lead researcher Rafeka Hossain, the magnitude of the association—especially for hip fractures—was striking. Women with higher cardiovascular risk also experienced fractures earlier, with hip fractures occurring around 15 years compared to nearly 20 years in lower-risk groups.

Several biological mechanisms may explain this connection, including chronic inflammation, oxidative stress, impaired calcium regulation, and reduced blood flow to bones due to atherosclerosis. Hormonal changes after menopause may further amplify both cardiovascular and bone health risks.

The findings suggest that cardiovascular risk assessments could help identify women who may benefit from early bone health screening. Experts emphasize that lifestyle strategies—such as regular exercise, a calcium- and vitamin D-rich diet, smoking cessation, and managing conditions like diabetes—can support both heart and bone health.

REFERENCE: Hossain, R., et al. (2026). The association between 10-year cardiovascular risk and fracture incidence in postmenopausal women: a prospective analysis from the Women’s Health Initiative. The Lancet Regional Health - Americas. DOI: 10.1016/j.lana.2026.101440. 

Review Finds Camel Milk May Offer Health Benefits but Warns Against Raw Consumption

A comprehensive review published in Food Science & Nutrition examines the growing evidence on camel milk as a functional food with potential therapeutic benefits. Analyzing studies from 2000 to 2025, researchers highlight its unique nutritional profile, including insulin-like proteins, bioactive peptides, antibodies, and exosomes that may contribute to metabolic and immune health.

Traditionally used in regions of Africa and Asia, camel milk has long been valued for both nutrition and medicinal purposes. Modern research now supports some of these claims, suggesting it may offer advantages over cow’s milk.

Unlike bovine milk, camel milk has a different protein composition with lower allergenic potential, making it a possible alternative for individuals with dairy sensitivities. It also shows greater stability under refrigeration, maintaining quality longer than conventional milk.

Clinical and experimental findings indicate potential benefits in Type 2 Diabetes, with one randomized trial showing significant reductions in fasting blood glucose and HbA1c after regular consumption.

Studies also report improvements in children with Autism Spectrum Disorder, possibly due to anti-inflammatory and antioxidant effects. Additionally, its high lactoferrin content may provide antimicrobial activity against pathogens such as Salmonella, while small trials suggest benefits in asthma management.

Despite these promising findings, the review emphasizes important safety concerns. Consuming raw, unpasteurized camel milk carries risks of zoonotic infections, including Brucellosis and Salmonella contamination. Pasteurization is therefore strongly recommended to ensure safety.

Overall, camel milk shows potential as a nutritionally rich, therapeutic food. However, the evidence remains heterogeneous, combining clinical, animal, and laboratory studies.

Larger, well-designed human trials are needed to confirm its efficacy, determine optimal dosages, and establish its role in modern dietary and medical practices.

REFERENCE: Bereda, G., Uthirapathy, S., & Ahamad, J. (2026). Camel Milk as a Functional Food: Nutritional Composition, Health‐Promoting Benefits, and Safety Considerations. Food Science & Nutrition, 14(3). DOI – 10.1002/fsn3.71638, 

Researchers Identify High-Risk Health Combination Linked to 83 Percent Higher Mortality

A collaborative study by Federal University of São Carlos and University College London has found that the combination of excess abdominal fat and low muscle mass significantly increases mortality risk. Individuals with both conditions were 83% more likely to die compared to those with neither risk factor.

This dangerous combination is known as Sarcopenic Obesity, a condition in which muscle mass declines while body fat increases. It is particularly common in older adults and is associated with reduced mobility, loss of independence, frailty, and a higher risk of falls and chronic health complications.

Researchers explain that excess fat contributes to chronic inflammation, which accelerates muscle breakdown. Fat can also infiltrate muscle tissue, further impairing its function. This process disrupts key metabolic, endocrine, and immune pathways, weakening the body’s overall physiological resilience. Over time, these changes can significantly affect quality of life and increase vulnerability to disease and death.

One major challenge in addressing sarcopenic obesity has been the lack of a standardized definition. To overcome this, the research team proposed simple, practical measures for early identification. Abdominal obesity was defined using waist circumference—greater than 102 cm in men and 88 cm in women—while low muscle mass was assessed using skeletal muscle mass index thresholds.

These accessible measurements could help clinicians identify at-risk individuals earlier without relying on complex or expensive diagnostic tools. Early detection is crucial, as targeted interventions such as resistance training, improved nutrition, and weight management strategies may help reverse or slow the progression of the condition.

The findings highlight the importance of not just monitoring body weight, but also assessing body composition. Addressing both fat accumulation and muscle loss is essential for improving long-term health outcomes and reducing mortality risk.

REFERENCE: Valdete Regina Guandalini, Patrícia Silva Tofani, Sara Souza Lima, Letícia Coelho Silveira, Natália Cochar-Soares, Thais Barros Pereira da Silva, Thales Batista de Souza, Mariane Marques Luiz, Paula Camila Ramírez, Roberta de Oliveira Máximo, Andrew Steptoe, Cesar de Oliveira, Tiago da Silva Alexandre. Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk? Aging Clinical and Experimental Research, 2024; 36 (1) DOI: 10.1007/s40520-024-02866-9